205 related articles for article (PubMed ID: 32640498)
21. Shaping of CD56
Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2019; 10():547. PubMed ID: 30949182
[TBL] [Abstract][Full Text] [Related]
22. Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles.
Bertani G; Santoleri L; Ferri U; Marenco P; Grillo G; Zucchetti E; Forno B; Lando G; Scarpati B; Cairoli R; Rossini S; Cesana C
Transfusion; 2016 Feb; 56(2):505-10. PubMed ID: 26453579
[TBL] [Abstract][Full Text] [Related]
23. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
Flowers ME; Apperley JF; van Besien K; Elmaagacli A; Grigg A; Reddy V; Bacigalupo A; Kolb HJ; Bouzas L; Michallet M; Prince HM; Knobler R; Parenti D; Gallo J; Greinix HT
Blood; 2008 Oct; 112(7):2667-74. PubMed ID: 18621929
[TBL] [Abstract][Full Text] [Related]
24. Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.
Franklin C; Cesko E; Hillen U; Schilling B; Brandau S
PLoS One; 2015; 10(8):e0134518. PubMed ID: 26241482
[TBL] [Abstract][Full Text] [Related]
25. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure.
Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M
J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140
[TBL] [Abstract][Full Text] [Related]
26. Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD.
Dignan FL; Aguilar S; Scarisbrick JJ; Shaw BE; Potter MN; Cavenagh J; Apperley JF; Fielding AK; Pagliuca A; Raj K; Marks DI; Peniket A; Crawley C; Koh MB; Child FJ
Bone Marrow Transplant; 2014 May; 49(5):704-8. PubMed ID: 24566709
[TBL] [Abstract][Full Text] [Related]
27. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
[TBL] [Abstract][Full Text] [Related]
28. Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response.
Piccirillo N; Putzulu R; Massini G; Di Giovanni A; Giammarco S; Metafuni E; Sica S; Zini G; Chiusolo P
J Clin Apher; 2021 Feb; 36(1):118-126. PubMed ID: 33058243
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
[TBL] [Abstract][Full Text] [Related]
30. Cost comparison of extracorporeal photopheresis technologies at the European Institute of Oncology.
Magarò A; Lucchetti B; Caime A; Lionetti MT; Laszlo D
J Clin Apher; 2021 Jun; 36(3):364-369. PubMed ID: 33476456
[TBL] [Abstract][Full Text] [Related]
31. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids.
Denney HA; Whittle RJ; Lai J; Jacques RM; Taylor PC
Transplantation; 2017 Jan; 101(1):204-211. PubMed ID: 27007227
[TBL] [Abstract][Full Text] [Related]
32. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients.
Uygun V; Daloglu H; Karasu G; Hazar V; Yeşilipek A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):209-14. PubMed ID: 25374287
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.
Dignan FL; Greenblatt D; Cox M; Cavenagh J; Oakervee H; Apperley JF; Fielding AK; Pagliuca A; Mufti G; Raj K; Marks DI; Amrolia P; Peniket A; Medd P; Potter MN; Shaw BE; Scarisbrick JJ
Bone Marrow Transplant; 2012 Jun; 47(6):824-30. PubMed ID: 21927038
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
Whittle RM; Denney H; Chantry AD; Alfred A; Taylor PC
J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
[TBL] [Abstract][Full Text] [Related]
35. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy.
Rubegni P; Sbano P; Cevenini G; Perari MG; Marotta G; Risulo M; Carcagnì MR; D' Ascenzo G; De Aloe G; Fimiani M
Int J Immunopathol Pharmacol; 2007; 20(4):801-7. PubMed ID: 18179753
[TBL] [Abstract][Full Text] [Related]
36. A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease.
Kitko CL; Abdel-Azim H; Carpenter PA; Dalle JH; Diaz-de-Heredia C; Gaspari S; Gennery AR; Handgretinger R; Lawitschka A
Transplant Cell Ther; 2022 May; 28(5):261.e1-261.e7. PubMed ID: 35124293
[TBL] [Abstract][Full Text] [Related]
37. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response.
Seaton ED; Szydlo RM; Kanfer E; Apperley JF; Russell-Jones R
Blood; 2003 Aug; 102(4):1217-23. PubMed ID: 12714516
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System.
Hautmann AH; Wolff D; Hahn J; Edinger M; Schirmer N; Ammer J; Holler B; Landfried K; Hautmann MG; Ahrens N; Ugocsai P; Andreesen R; Holler E
Bone Marrow Transplant; 2013 Mar; 48(3):439-45. PubMed ID: 22922407
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
40. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Greinix HT; Worel N; Knobler R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
